Drug Name |
Sevelamer hydrochloride |
Drug ID |
BADD_D02014 |
Description |
Sevelamer is a phosphate binding drug used to prevent hyperphosphataemia in patients with chronic renal failure. It is marketed by Genzyme under the trade name Renagel. |
Indications and Usage |
For the control of serum phosphorus in patients with Chronic Kidney Disease (CKD) on hemodialysis. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
V03AE02 |
DrugBank ID |
DB00658
|
KEGG ID |
D01983
|
MeSH ID |
D000069603
|
PubChem ID |
159247
|
TTD Drug ID |
D03MZQ
|
NDC Product Code |
70748-173; 70748-172; 66499-0020; 62147-0077; 68462-446; 0955-1048; 60687-449; 59349-0017; 59651-079; 76339-146; 68462-447; 58468-0021 |
Synonyms |
Sevelamer | GT335-012 | GT335 012 | GT335012 | Sevelamer Hydrochloride | Hydrochloride, Sevelamer | RenaGel | Sevelamer Carbonate | Carbonate, Sevelamer |